Literature DB >> 15026716

[Treatment of Graves' disease: 300 cases].

Insaf Hadj Ali1, Karima Khiari, Lotfi Chérif, Néjib Ben Abdallah, Hédi Ben Maïz, Héla Hajri, Mohamed Ferjaoui.   

Abstract

OBJECTIVE: To try to select the best treatment among synthetic anti-thyroid agents, surgery and radioiodine in the case of Graves' disease.
METHOD: We present a retrospective study of therapeutic and progressive aspects of 300 cases of Graves' disease.
RESULTS: At the time of the diagnosis, the patients' mean age was of 38.17 years. Female sex predominated (70.7%). Medical treatment was prescribed in 25.7% of cases. Agranulocytosis occurred in one patient who died from septic shock. Surgery was performed in 29.3% of patients and 41% were treated with radioactive iodine. After a mean follow-up of 53.7 months, a progression towards euthyroidism was noted in 60, 22.7 and 21.7% of patients treated respectively with antithyroid drugs, surgery and radioiodine. Hypothyroidism was noted in around 40% of cases, 57.8% of which were treated surgically. Recurrent hyperthyroidism is more frequent with antithyroid drugs.
CONCLUSION: Medical treatment increases the risk of relapse. It is therefore preferable to apply radical treatments in order to obtain permanent remission from hyperthyroidism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026716     DOI: 10.1016/s0755-4982(04)98466-7

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  1 in total

1.  Effects of bone marrow cell transplant on thyroid function in an I131-induced low T4 and elevated TSH rat model.

Authors:  Gustavo E Guajardo-Salinas; Juan A Carvajal; Angel A Gaytan-Ramos; Luis Arroyo; Alberto G López-Reyes; José F Islas; Beiman G Cano; Netzahualcoyótl Arroyo-Currás; Alfredo Dávalos; Gloria Madrid; Jorge E Moreno-Cuevas
Journal:  J Negat Results Biomed       Date:  2007-01-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.